Dr Satveer Mahil
Consultant Dermatologist, Reader
Biography
Dr Satveer Mahil is a Consultant Dermatologist at St John's Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust and Reader at King's College London. She graduated from the University of Cambridge and completed integrated academic training (NIHR Academic Clinical Fellowship and NIHR Clinical Lectureship) in Dermatology at St John's Institute of Dermatology. During her MRC-funded PhD, she used genetic information to gain novel insights into the mechanistic basis of different forms of psoriasis and define new therapeutic targets. After her PhD, she was awarded an MRC Clinical Academic Research Partnership Award and she currently holds an NIHR Advanced Fellowship. Her translational research seeks to optimise outcomes for individuals with inflammatory skin diseases including psoriasis and eczema. She is director of St John's DermAcademy (dermatology education academy).
Teaching
Dr Satveer Mahil is the Director of St John's DermAcademy.
Research
Skin Therapy Research Unit
The Skin Therapy Research Unit (STRU) is a dermatology research and clinical trials facility based at St John’s Institute of Dermatology within Guy’s and St Thomas’ NHS Foundation Trust and King’s College, London.
News
Meet the Spinouts on King's Spinout Accelerator
10 spinouts derived from King’s research community will explore the commercial potential of their research on the King’s Spinout Accelerator.
Understanding early effects of psoriasis drug offers potential for personalised treatment
Academic researchers from King’s College London have investigated the early effects of an immunosuppressant drug, which could help clinicians with future...
Research
Skin Therapy Research Unit
The Skin Therapy Research Unit (STRU) is a dermatology research and clinical trials facility based at St John’s Institute of Dermatology within Guy’s and St Thomas’ NHS Foundation Trust and King’s College, London.
News
Meet the Spinouts on King's Spinout Accelerator
10 spinouts derived from King’s research community will explore the commercial potential of their research on the King’s Spinout Accelerator.
Understanding early effects of psoriasis drug offers potential for personalised treatment
Academic researchers from King’s College London have investigated the early effects of an immunosuppressant drug, which could help clinicians with future...